Controlling a key enzyme involved in cancer and neurodegenerative diseases
Dialing down caspase-7 through allosteric control: An integrated approach
This study is exploring new ways to control an enzyme called caspase-7, which is involved in certain cancers and brain diseases, by using small molecules that can change how it works; the goal is to find better treatments for people affected by these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10649449 on NIH RePORTER |
What this research studies
This research investigates how to regulate the activity of caspase-7, an enzyme linked to various cancers and neurodegenerative diseases, using small molecules that bind to an allosteric site. By employing advanced techniques like Fragment Based Drug Discovery, X-ray crystallography, and molecular dynamics, the team aims to develop new inhibitors that can effectively modulate the enzyme's function without directly targeting its active site. This approach could lead to more selective and effective treatments for conditions where caspase-7 is dysregulated.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers or neurodegenerative diseases where caspase-7 plays a significant role.
Not a fit: Patients with conditions unrelated to caspase-7 dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that more effectively manage or treat cancers and neurodegenerative diseases by precisely controlling enzyme activity.
How similar studies have performed: Previous research has shown promise in targeting allosteric sites in other enzymes, suggesting potential success for this novel approach.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Spies, Michael Ashley — University of Iowa
- Study coordinator: Spies, Michael Ashley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.